Written by: Kirollos S. Hanna, PharmD, BCPS, BCOP – University of Minnesota Medical Center & Mayo Clinic
Download Here

This PQI will discuss optimal prevention and control of CINV which has been associated with improved adherence to oncolytic therapy.
Continue reading Chemotherapy Induced Nausea and Vomiting

Read More

Written by Julianne Orr, PharmD, Indiana University Health Simon Cancer Center
Download Here

Olanzapine (Zyprexa) is an FDA approved atypical antipsychotic that blocks multiple neuronal receptors involved in nausea/vomiting pathways.  This PQI will review the appropriate use of olanzapine for prevention and treatment of CINV.
Continue reading Olanzapine (Zyprexa) in Chemotherapy Induced Nausea and Vomiting

Read More